| Ytd | 73.82% | |
| 1y | 87.43% |
| Open | 31.74 | Prev Close | 31.52 | Low | 30.77 | High | 31.92 | Mkt Cap | 806.03M |
| Vol | 569.93K | Avg Vol | 269.64K | EPS | -1.42 | P/E | N/A | Forward P/E | -21.54 |
| Beta | 1.16 | Short Ratio | 4.59 | Inst. Own | 71.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-27 | 50-d Avg | 23.23 | 200-d Avg | 19.50 | 1yr Est | 40.17 |
OrthoPediatrics (KIDS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about
Lake Street analyst Ben Haynor maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the
Canaccord Genuity analyst Caitlin Roberts maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and
Truist Securities analyst Ravi Misra maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and rais
Gainers Pulmonx (NASDAQ:LUNG) stock increased by 33.1% to $2.63 during Wednesday's regular sess
TD Cowen analyst Mathew Blackman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises th
Stifel analyst Rick Wise maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price
Piper Sandler analyst Matt O'Brien reiterates OrthoPediatrics (NASDAQ:KIDS) with a Overweight
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the pri
OrthoPediatrics Corp. ( KIDS ) Q3 2026 Earnings Call October 27, 2026 4:30 PM EDT Company Participan
OrthoPediatrics raised 2026 revenue guidance to $270 million to $273 million. Third-quarter revenue
OrthoPediatrics NASDAQ: KIDS reported record third-quarter revenue and raised its full-year sales ou
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus
OrthoPediatrics (NASDAQ:KIDS) reported third-quarter financial results on Tuesday. The transcript fr
Gainers Neumora Therapeutics (NASDAQ:NMRA) shares rose 11.9% to $0.41 during Tuesday's after-ma
OrthoPediatrics (NASDAQ:KIDS) raises FY2026 sales outlook from $265.000 million-$269.000 million to
OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.23) per share which missed the analys
Record Third Quarter 2026 Revenue of $72.7 Million , Up 19% Year-over-Year
New addition to the Pediatric Nailing Platform expands options for pediatric femoral trauma and defo
Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial marke
SAN FRANCISCO--(BUSINESS WIRE)--Pottery Barn Kids and Pottery Barn Teen, portfolio brands of William
OrthoPediatrics (NASDAQ: KIDS - Get Free Report) and Trinity Biotech (NASDAQ: TRIB - Get Free Report
WARSAW, Ind., Oct. 13, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Com
SOUR PATCH KIDS to Launch New Halloween Candy and Inspire Mischief-Making on Social Media, Featuring
SS Innovations International (NASDAQ: SSII - Get Free Report) and OrthoPediatrics (NASDAQ: KIDS - Ge
WARSAW, Ind., Oct. 07, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Com
Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial marke
Milestone program with record attendance brought together 39 participants from 23 institutions acros
WARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Co
On September 17, 2026, OrthoPediatrics Corp (KIDS) shares fell 6.0%, bringing the current price to $
Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial marke
OrthoPediatrics Corp. (NASDAQ: KIDS - Get Free Report) major shareholder Jennifer Pritzker sold 302,
OrthoPediatrics Corp. (NASDAQ: KIDS - Get Free Report) Director David Pelizzon sold 302,369 shares o
Following a highly successful limited launch period that resulted in over 350 surgical implantations
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the pri
Piper Sandler analyst Matt O'Brien reiterates OrthoPediatrics (NASDAQ:KIDS) with a Overweight
Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the pri
OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.26) per share which beat the analyst
OrthoPediatrics (NASDAQ:KIDS) raises FY2026 sales outlook from $263.000 million-$267.000 million to
Gainers Gossamer Bio (NASDAQ:GOSS) shares rose 28.8% to $0.26 during Monday's after-market sess
Truist Securities analyst Richard Newitter maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold an
OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company
Mark Cuban offered his advice for those seeking jobs in the era of artificial intelligence (AI), hig